A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Blacktown Cancer and Haematology Centre, Blacktown

Nucleus Network, Melbourne

Austin Health, Heidelberg

Monash Health, Clayton

Icon Cancer Foundation, South Brisbane

Linear Clinical Research, Nedlands

Beijing Cancer Hospital, Beijing

The First Hospital of China Medical University, Shenyang

The First Hospital of Jilin University, Changchun

Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing

Jinan Central Hospital, Jinan

Shandong Cancer Hospital, Jinan

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The First Affiliated Hospital of Xiamen University, Xiamen

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan

Henan Cancer Hospital, Zhengzhou

Guangdong Provincial Peoples Hospital, Guangzhou